InsidersTradesSigma
Oncopeptides AB Stock: price and insider trades · Finland · FIN-FSA
Track the Oncopeptides AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Oncopeptides AB has logged 6 reports. Market capitalisation: €648m. The latest transaction was disclosed on 18 March 2026 (Purchase). Among the most active insiders: Per Wold-Olsen. All data is accessible without an account.
6
Insider Decl.
0
Thresholds
€107,697
6 ops.
Buy Volume
·
0 ops.
Sell Volume
33Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 18 March 2026
Declarations6 total
14,631 shares@ €0.15110.0003% mcap100.0% of flowAktieFI:A003X111-1
Ideal exit: 12 Dec 2026 (T+270)
140,232 shares@ €0.14320.0031% mcap100.0% of flowBTA (betald tecknad aktie)FI:A003X096-1
Ideal exit: 11 Dec 2026 (T+270)
418,876 shares@ €0.14410.0092% mcap72.2% of flowBTA (betald tecknad aktie)FI:A003X103-1
Ideal exit: 12 Dec 2026 (T+270)
79,590 shares@ €0.29210.0036% mcap27.8% of flowBTA (betald tecknad aktie)FI:A003S333-1
Ideal exit: 13 Jun 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
1,000 shares@ €0.42890.0001% mcap23.8% of flowAktieFI:A003R768-1
Ideal exit: 23 May 2026 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
3,500 shares@ €0.39290.0002% mcap76.2% of flowAktieFI:A003R706-1
Ideal exit: 22 May 2026 (T+270)
6 of 6 declarations